|
Volumn 54, Issue SUPPL. 1, 2005, Pages
|
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 [4 [3 (2,5 DIMETHYLPYRROLIDINYL)PROPOXY]PHENYL]PHENYLMORPHOLIN 4 YLKETONE;
A 317920;
A 349821;
FURAN 2 CARBOXYLIC ACID[2 [4 [3 (4 CYCLOPROPANECARBONYLPHENOXY)PROPYL] PIPERAZIN 1 YL] 1 METHYL 2 OXOETHYL]AMIDE;
HISTAMINE H3 RECEPTOR;
HISTAMINE H3 RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
HUMAN;
HUMAN TISSUE;
ISOTOPE LABELING;
NONHUMAN;
RAT;
RECEPTOR AFFINITY;
ANIMALS;
BIPHENYL COMPOUNDS;
CELL LINE;
HISTAMINE AGONISTS;
HUMANS;
IMIDAZOLES;
MOLECULAR STRUCTURE;
PIPERAZINES;
RADIOLIGAND ASSAY;
RATS;
RECEPTORS, HISTAMINE H3;
|
EID: 21144439214
PISSN: 10233830
EISSN: None
Source Type: Journal
DOI: 10.1007/s00011-004-0421-y Document Type: Conference Paper |
Times cited : (2)
|
References (5)
|